UTMB drug discovery partnership awarded $56 million grant
EurekAlert!, May 18, 2022
Thanks to a $56 million grant, the University of Texas Medical Branch and global health care company Novartis will enhance their work together to discover drugs to fight off the next pandemic. The grant comes from the National Institute of Allergy and Infectious Diseases (NIAID) and is one of nine such grants awarded by NIAID to establish Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern. “We must prepare for the next pandemic by working together across governmental, non-governmental, academic and private sectors to develop an arsenal of countermeasures,” said Dr. Pei-Yong Shi, a professor in the Department of Biochemistry & Molecular Biology and VP for Research Innovation at UTMB and one of the leaders of the partnership. Many national and international sites also posted this news, including Pharmabiz, Medical News and Study Finds.